Categories Menu

New diet pill containing topamax

Forum Forums Research Conversation New diet pill containing topamax

This topic contains 0 replies, has 1 voice, and was last updated by  ininpedi1974 4 months, 4 weeks ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #168110

    ininpedi1974
    Participant


    CLICK HERE CLICK HERE CLICK HERE CLICK HERE CLICK HERE
    Topiramate (brand name Topamax) is an anticonvulsant (antiepilepsy) drug. In late 2012, topiramate was approved by the United States Food and Drug Administration (FDA) in combination with phentermine for weight loss.Learn about Topamax (Topiramate) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.Topamax official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.Successful Weight Loss and wellness involves a formula with many aspects, including appropriate nutrition, stress relief, and treatment. Call 615-822-9002Note: Press announcements from 2004 to 2015 are available through the FDA.gov Archive.Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.Topiramate (brand name Topamax) is an anticonvulsant (antiepilepsy) drug. In late 2012, topiramate was approved by the United States Food and Drug Administration (FDA) in combination with phentermine for weight loss.Learn about Topamax (Topiramate) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.Topamax official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.Successful Weight Loss and wellness involves a formula with many aspects, including appropriate nutrition, stress relief, and treatment. Call 615-822-9002Note: Press announcements from 2004 to 2015 are available through the FDA.gov Archive.Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.